Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by C.P. Riedl. Director active across 1 company, notably Vivoryon Therapeutics N.V.. Cumulatively, 4 reports have been published. Activity tracked since 22 June 2022. The latest transaction was disclosed on 30 June 2025 (Purchase). Regulator: AFM. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
C.P. Riedl is a declarant linked to Vivoryon Therapeutics N.V. on XAMS, where the listed relationship is Director or Supervisory Board. The record shows 4 filings in total, and the 4 sampled filings run from 2022-06-22 to 2025-06-30, with a modal transaction nature of Purchase and buy and sell amounts of EUR 0 in this recent sample.